- Page 1 and 2:
WORLD HEALTH ORGANIZATION INTERNATI
- Page 3 and 4:
IARC MONOGRAPHS In 1969, the Intern
- Page 5 and 6:
iv IARC MONOGRAPHS VOLUME 82 3.2 Th
- Page 7 and 8:
vi IARC MONOGRAPHS VOLUME 82 SOME M
- Page 10 and 11:
IARC WORKING GROUP ON THE EVALUATIO
- Page 12 and 13:
PARTICIPANTS 5 Observer, representi
- Page 14:
PREAMBLE
- Page 17 and 18:
10 IARC MONOGRAPHS VOLUME 82 plasms
- Page 19 and 20:
12 IARC MONOGRAPHS VOLUME 82 collec
- Page 21 and 22:
14 agents present. For processes, i
- Page 23 and 24:
16 IARC MONOGRAPHS VOLUME 82 Finall
- Page 25 and 26:
18 IARC MONOGRAPHS VOLUME 82 and mi
- Page 27 and 28:
20 IARC MONOGRAPHS VOLUME 82 (c) St
- Page 29 and 30:
22 IARC MONOGRAPHS VOLUME 82 may le
- Page 31 and 32:
24 IARC MONOGRAPHS VOLUME 82 It is
- Page 33 and 34:
26 IARC MONOGRAPHS VOLUME 82 Data r
- Page 35 and 36:
28 when there is strong evidence th
- Page 37 and 38:
30 IARC MONOGRAPHS VOLUME 82 Vol. 7
- Page 40 and 41:
GENERAL REMARKS ON THE SUBSTANCES C
- Page 42 and 43:
GENERAL REMARKS ON THE SUBSTANCES C
- Page 44:
GENERAL REMARKS ON THE SUBSTANCES C
- Page 48:
SOME TRADITIONAL HERBAL MEDICINES
- Page 51 and 52:
44 which may include, for example,
- Page 53 and 54:
46 2. Use of Traditional Herbal Med
- Page 55 and 56:
48 IARC MONOGRAPHS VOLUME 82 decade
- Page 57 and 58:
50 IARC MONOGRAPHS VOLUME 82 Table
- Page 59 and 60:
52 3.2.1 Definition of herbal medic
- Page 61 and 62:
54 3.2.8 Individual supply Herbal m
- Page 63 and 64:
56 IARC MONOGRAPHS VOLUME 82 Table
- Page 65 and 66:
58 3.3.2 Germany (see Kraft, 1999;
- Page 67 and 68:
60 beyond placebo, and this informa
- Page 69 and 70:
62 3.3.5 Canada The Canadian Food a
- Page 71 and 72:
64 of adverse reactions to OTC drug
- Page 73 and 74:
66 IARC MONOGRAPHS VOLUME 82 3.3.12
- Page 75 and 76:
68 IARC MONOGRAPHS VOLUME 82 Jellin
- Page 77 and 78:
70 IARC MONOGRAPHS VOLUME 82 Simila
- Page 79 and 80:
72 IARC MONOGRAPHS VOLUME 82 Figure
- Page 81 and 82:
74 diameter of 4-6 cm or more, lobe
- Page 83 and 84:
76 1.2 Use 1.2.1 Aristolochia conto
- Page 85 and 86:
78 1.3.3 Aristolochia fangchi Compo
- Page 87 and 88:
80 1.6.2 Structural and molecular f
- Page 89 and 90:
82 chromatographic separation with
- Page 91 and 92:
84 may contain aristolochic acids.
- Page 93 and 94:
86 IARC MONOGRAPHS VOLUME 82 A bila
- Page 95 and 96:
88 received distilled water. The an
- Page 97 and 98:
90 IARC MONOGRAPHS VOLUME 82 Figure
- Page 99 and 100:
92 varied from undetectable (< 0.02
- Page 101 and 102:
94 lochic acids enhanced immune res
- Page 103 and 104:
96 4.4 Genetic and related effects
- Page 105 and 106:
Table 3 (contd) Details of study DN
- Page 107 and 108:
Table 4. DNA adduct formation with
- Page 109 and 110:
Table 4 (contd) Details of study Co
- Page 111 and 112:
Table 5 (contd) Species Treatment I
- Page 113 and 114:
Table 6. DNA adduct formation by ar
- Page 115 and 116:
Table 6 (contd) Test system Assay D
- Page 117 and 118:
Table 6 (contd) Test system Assay D
- Page 119 and 120:
Table 7. Polymerase action on arist
- Page 121 and 122:
Table 8 (contd) Test system Drosoph
- Page 123 and 124:
116 of the forestomach and lung of
- Page 125 and 126:
118 lochic acid II (three metabolit
- Page 127 and 128:
120 IARC MONOGRAPHS VOLUME 82 Che,
- Page 129 and 130:
122 IARC MONOGRAPHS VOLUME 82 Healt
- Page 131 and 132:
124 IARC MONOGRAPHS VOLUME 82 Nishi
- Page 133 and 134:
126 IARC MONOGRAPHS VOLUME 82 Schme
- Page 135 and 136:
128 IARC MONOGRAPHS VOLUME 82 Yang,
- Page 137 and 138:
130 Figure 1. Morinda officinalis H
- Page 139 and 140:
132 1.3.2 Morinda officinalis A num
- Page 141 and 142:
134 by Soxhlet extraction with ethy
- Page 143 and 144:
136 2.1 Case-control studies 2.1.1
- Page 145 and 146:
138 3. Studies of Cancer in Experim
- Page 147 and 148:
140 1,3-Dihydroxy-2-hydroxymethylan
- Page 149 and 150:
142 4.3 Reproductive and developmen
- Page 151 and 152:
Table 1 (contd) Test system Result
- Page 153 and 154:
146 5.1 Exposure data 5. Summary of
- Page 155 and 156:
148 IARC MONOGRAPHS VOLUME 82 Brigg
- Page 157 and 158:
150 IARC MONOGRAPHS VOLUME 82 Nusko
- Page 160 and 161:
D. SENECIO SPECIES AND RIDDELLIINE
- Page 162 and 163:
metry (Witte et al., 1992). Thin-la
- Page 164 and 165:
sex were killed after a seven-week
- Page 166 and 167:
4.2.2 Experimental systems SOME TRA
- Page 168 and 169:
Table 1. Genetic and related effect
- Page 170 and 171:
Riddelliine induced unscheduled DNA
- Page 172 and 173:
5.3 Animal carcinogenicity data In
- Page 174 and 175:
SOME TRADITIONAL HERBAL MEDICINES 1
- Page 176:
SOME MYCOTOXINS
- Page 179 and 180:
172 Aflatoxin G 1 IARC MONOGRAPHS V
- Page 181 and 182:
174 IARC MONOGRAPHS VOLUME 82 Table
- Page 183 and 184:
Table 2 (contd) Method no. Aflatoxi
- Page 185 and 186:
178 indicates that A. flavus and A.
- Page 187 and 188:
Table 4. Occurrence of aflatoxin B1
- Page 189 and 190:
182 IARC MONOGRAPHS VOLUME 82 aflat
- Page 191 and 192:
Table 6. Co-occurrence of aflatoxin
- Page 193 and 194:
186 IARC MONOGRAPHS VOLUME 82 Figur
- Page 195 and 196:
188 1.4 International exposure esti
- Page 197 and 198:
190 (c) Impact of establishing maxi
- Page 199 and 200:
192 IARC MONOGRAPHS VOLUME 82 used
- Page 201 and 202:
194 IARC MONOGRAPHS VOLUME 82 aflat
- Page 203 and 204:
Table 10 (contd) Reference Area Uni
- Page 205 and 206:
198 were collapsed into a conventio
- Page 207 and 208:
Table 11 (contd) Reference Area Stu
- Page 209 and 210:
202 IARC MONOGRAPHS VOLUME 82 histo
- Page 211 and 212:
204 IARC MONOGRAPHS VOLUME 82 resid
- Page 213 and 214:
Table 12. Summary of principal case
- Page 215 and 216:
208 IARC MONOGRAPHS VOLUME 82 disea
- Page 217 and 218:
210 3. Studies of Cancer in Experim
- Page 219 and 220:
212 IARC MONOGRAPHS VOLUME 82 diet
- Page 221 and 222:
214 3.4 Administration with known c
- Page 223 and 224:
216 IARC MONOGRAPHS VOLUME 82 The 8
- Page 225 and 226:
218 observed in rat liver slices, a
- Page 227 and 228:
220 IARC MONOGRAPHS VOLUME 82 Figur
- Page 229 and 230:
222 IARC MONOGRAPHS VOLUME 82 an α
- Page 231 and 232:
224 (mainly hepatocellular carcinom
- Page 233 and 234:
226 IARC MONOGRAPHS VOLUME 82 but i
- Page 235 and 236:
228 lordosis and reduction in conce
- Page 237 and 238:
230 IARC MONOGRAPHS VOLUME 82 Table
- Page 239 and 240:
232 IARC MONOGRAPHS VOLUME 82 sampl
- Page 241 and 242:
234 In eight subjects (four from Ho
- Page 243 and 244:
Table 16 (contd) Test system Result
- Page 245 and 246:
238 IARC MONOGRAPHS VOLUME 82 aflat
- Page 247 and 248:
240 IARC MONOGRAPHS VOLUME 82 anima
- Page 249 and 250:
242 difference between the two stud
- Page 251 and 252:
244 IARC MONOGRAPHS VOLUME 82 HBV-t
- Page 253 and 254:
246 In a large cohort study in Shan
- Page 255 and 256:
248 experimental data in showing th
- Page 257 and 258:
250 IARC MONOGRAPHS VOLUME 82 Ander
- Page 259 and 260:
252 IARC MONOGRAPHS VOLUME 82 Buetl
- Page 261 and 262:
254 IARC MONOGRAPHS VOLUME 82 Denis
- Page 263 and 264:
256 IARC MONOGRAPHS VOLUME 82 Galla
- Page 265 and 266:
258 IARC MONOGRAPHS VOLUME 82 Heino
- Page 267 and 268:
260 IARC MONOGRAPHS VOLUME 82 Jalon
- Page 269 and 270:
262 IARC MONOGRAPHS VOLUME 82 Kirk,
- Page 271 and 272:
264 IARC MONOGRAPHS VOLUME 82 Lunn,
- Page 273 and 274:
266 IARC MONOGRAPHS VOLUME 82 Olubu
- Page 275 and 276:
268 IARC MONOGRAPHS VOLUME 82 Roll,
- Page 277 and 278:
270 IARC MONOGRAPHS VOLUME 82 Stett
- Page 279 and 280:
272 IARC MONOGRAPHS VOLUME 82 Verge
- Page 281 and 282:
274 IARC MONOGRAPHS VOLUME 82 Yang,
- Page 283 and 284:
Table 1. IARC evaluations Previous
- Page 285 and 286:
278 kernels and in less than 0.1% o
- Page 287 and 288:
280 2.5.3 Cottonseed A. flavus is a
- Page 289 and 290:
282 IARC MONOGRAPHS VOLUME 82 aflat
- Page 291 and 292:
284 IARC MONOGRAPHS VOLUME 82 aflat
- Page 293 and 294:
286 IARC MONOGRAPHS VOLUME 82 Table
- Page 295 and 296:
288 IARC MONOGRAPHS VOLUME 82 Figur
- Page 297 and 298:
290 IARC MONOGRAPHS VOLUME 82 Table
- Page 299 and 300:
292 IARC MONOGRAPHS VOLUME 82 aflat
- Page 301 and 302:
294 IARC MONOGRAPHS VOLUME 82 8. Re
- Page 303 and 304:
296 IARC MONOGRAPHS VOLUME 82 Guo,
- Page 305 and 306:
298 IARC MONOGRAPHS VOLUME 82 Marti
- Page 307 and 308:
300 IARC MONOGRAPHS VOLUME 82 Sharm
- Page 309 and 310:
302 (d ) Solubility: Soluble in wat
- Page 311 and 312:
304 1.4 Occurrence Fumonisins have
- Page 313 and 314:
306 Table 1 (contd) IARC MONOGRAPHS
- Page 315 and 316:
308 (c) Formation in commodities ot
- Page 317 and 318:
310 IARC MONOGRAPHS VOLUME 82 Table
- Page 319 and 320:
312 IARC MONOGRAPHS VOLUME 82 3.1 O
- Page 321 and 322:
314 3.2.2 Rat IARC MONOGRAPHS VOLUM
- Page 323 and 324:
316 with NDEA and fumonisin B 1, wh
- Page 325 and 326:
318 IARC MONOGRAPHS VOLUME 82 In pi
- Page 327 and 328:
Figure 2. Allometric relationship b
- Page 329 and 330:
322 IARC MONOGRAPHS VOLUME 82 obser
- Page 331 and 332:
324 IARC MONOGRAPHS VOLUME 82 Hepat
- Page 333 and 334:
326 4.2.3 Related studies IARC MONO
- Page 335 and 336:
328 4.3.2 Experimental systems IARC
- Page 337 and 338:
330 and litters on postnatal day 21
- Page 339 and 340:
Table 4. Genetic and related effect
- Page 341 and 342:
334 IARC MONOGRAPHS VOLUME 82 The f
- Page 343 and 344:
336 IARC MONOGRAPHS VOLUME 82 (d )
- Page 345 and 346:
338 IARC MONOGRAPHS VOLUME 82 treat
- Page 347 and 348:
340 4.5.2 Interference with fatty a
- Page 349 and 350:
342 IARC MONOGRAPHS VOLUME 82 Figur
- Page 351 and 352:
344 5.2 Human carcinogenicity data
- Page 353 and 354:
346 IARC MONOGRAPHS VOLUME 82 Alber
- Page 355 and 356:
348 IARC MONOGRAPHS VOLUME 82 Chamb
- Page 357 and 358:
350 IARC MONOGRAPHS VOLUME 82 Floss
- Page 359 and 360:
352 IARC MONOGRAPHS VOLUME 82 Hiroo
- Page 361 and 362:
354 IARC MONOGRAPHS VOLUME 82 Lee,
- Page 363 and 364:
356 IARC MONOGRAPHS VOLUME 82 Mobio
- Page 365 and 366:
358 IARC MONOGRAPHS VOLUME 82 Prelu
- Page 367 and 368:
360 IARC MONOGRAPHS VOLUME 82 Savar
- Page 369 and 370:
362 IARC MONOGRAPHS VOLUME 82 Steve
- Page 371 and 372:
364 IARC MONOGRAPHS VOLUME 82 Flett
- Page 373 and 374:
366 IARC MONOGRAPHS VOLUME 82 Yu, C
- Page 375 and 376:
368 disulfide, carbon tetrachloride
- Page 377 and 378:
Table 1 (contd) Sample matrix Sampl
- Page 379 and 380:
Table 3. Naphthalene production (th
- Page 381 and 382:
374 1.4 Occurrence 1.4.1 Natural oc
- Page 383 and 384:
Table 5. Occupational exposure to n
- Page 385 and 386:
378 water assuming a water concentr
- Page 387 and 388:
380 (Scheepers & Bos, 1992). The av
- Page 389 and 390:
382 (d ) Biodegradation Studies on
- Page 391 and 392: 384 IARC MONOGRAPHS VOLUME 82 Table
- Page 393 and 394: 386 3.2 Inhalation exposure 3.2.1 M
- Page 395 and 396: 388 3.3.2 Rat Ten BD I and BD III r
- Page 397 and 398: Figure 1. Main metabolic pathways o
- Page 399 and 400: 392 IARC MONOGRAPHS VOLUME 82 and t
- Page 401 and 402: 394 IARC MONOGRAPHS VOLUME 82 and 1
- Page 403 and 404: 396 IARC MONOGRAPHS VOLUME 82 1-240
- Page 405 and 406: 398 IARC MONOGRAPHS VOLUME 82 Perfu
- Page 407 and 408: 400 Siegel and Wason (1986) reviewe
- Page 409 and 410: 402 IARC MONOGRAPHS VOLUME 82 liver
- Page 411 and 412: 404 IARC MONOGRAPHS VOLUME 82 to id
- Page 413 and 414: 406 IARC MONOGRAPHS VOLUME 82 Alkal
- Page 415 and 416: 408 hyperplasia, atrophy, chronic i
- Page 417 and 418: 410 had deficient glucose-6-phospha
- Page 419 and 420: Table 10. Genetic and related effec
- Page 421 and 422: Table 10 (contd) Test system Micron
- Page 423 and 424: 416 assay with or without metabolic
- Page 425 and 426: 418 There is some evidence of devel
- Page 427 and 428: 420 IARC MONOGRAPHS VOLUME 82 Bjør
- Page 429 and 430: 422 IARC MONOGRAPHS VOLUME 82 Conkl
- Page 431 and 432: 424 IARC MONOGRAPHS VOLUME 82 Envir
- Page 433 and 434: 426 IARC MONOGRAPHS VOLUME 82 Ho, C
- Page 435 and 436: 428 IARC MONOGRAPHS VOLUME 82 Lynch
- Page 437 and 438: 430 IARC MONOGRAPHS VOLUME 82 O’B
- Page 439 and 440: 432 IARC MONOGRAPHS VOLUME 82 Schee
- Page 441: 434 IARC MONOGRAPHS VOLUME 82 Versc
- Page 445 and 446: 438 (e) Spectroscopy data: Infrared
- Page 447 and 448: 440 Methods of isotope-dilution GC-
- Page 449 and 450: 442 IARC MONOGRAPHS VOLUME 82 produ
- Page 451 and 452: 444 1.4 Occurrence A comprehensive
- Page 453 and 454: 446 IARC MONOGRAPHS VOLUME 82 In a
- Page 455 and 456: Table 4. Occupational exposure to s
- Page 457 and 458: Table 4 (contd) Country and year of
- Page 459 and 460: 452 IARC MONOGRAPHS VOLUME 82 study
- Page 461 and 462: 454 Completely insulating personal
- Page 463 and 464: 456 (a) Air IARC MONOGRAPHS VOLUME
- Page 465 and 466: 458 (see monograph in this volume);
- Page 467 and 468: 460 IARC MONOGRAPHS VOLUME 82 The F
- Page 469 and 470: 462 IARC MONOGRAPHS VOLUME 82 at th
- Page 471 and 472: Table 10. Characteristics of cohort
- Page 473 and 474: Table 10 (contd) Reference (country
- Page 475 and 476: 468 IARC MONOGRAPHS VOLUME 82 worke
- Page 477 and 478: 470 IARC MONOGRAPHS VOLUME 82 cance
- Page 479 and 480: 472 IARC MONOGRAPHS VOLUME 82 more
- Page 481 and 482: 474 mandelic acid samples were coll
- Page 483 and 484: 476 3.1.2 Rat Groups of 50 male and
- Page 485 and 486: 478 incidence of lung tumours was s
- Page 487 and 488: 480 1968; Engström et al., 1978a,b
- Page 489 and 490: 482 IARC MONOGRAPHS VOLUME 82 Many
- Page 491 and 492: 484 Haufroid et al. (2001) examined
- Page 493 and 494:
486 (c) Metabolism IARC MONOGRAPHS
- Page 495 and 496:
488 IARC MONOGRAPHS VOLUME 82 (1.07
- Page 497 and 498:
490 IARC MONOGRAPHS VOLUME 82 high
- Page 499 and 500:
492 IARC MONOGRAPHS VOLUME 82 accor
- Page 501 and 502:
494 IARC MONOGRAPHS VOLUME 82 posit
- Page 503 and 504:
496 IARC MONOGRAPHS VOLUME 82 guine
- Page 505 and 506:
498 IARC MONOGRAPHS VOLUME 82 pancr
- Page 507 and 508:
500 Styrene caused a dose-dependent
- Page 509 and 510:
502 On the basis of these results,
- Page 511 and 512:
504 4.4 Genetic and related effects
- Page 513 and 514:
506 IARC MONOGRAPHS VOLUME 82 repor
- Page 515 and 516:
508 (iv) Protein adducts Christakop
- Page 517 and 518:
510 showed increased levels of N7-d
- Page 519 and 520:
Table 14. Genetic and related effec
- Page 521 and 522:
514 increase in the induction of mi
- Page 523 and 524:
516 IARC MONOGRAPHS VOLUME 82 The r
- Page 525 and 526:
518 Circulating styrene 7,8-oxide m
- Page 527 and 528:
520 The increased risks for lymphat
- Page 529 and 530:
522 biologically significant extent
- Page 531 and 532:
524 IARC MONOGRAPHS VOLUME 82 Berga
- Page 533 and 534:
526 IARC MONOGRAPHS VOLUME 82 Chakr
- Page 535 and 536:
528 IARC MONOGRAPHS VOLUME 82 Darra
- Page 537 and 538:
530 IARC MONOGRAPHS VOLUME 82 Flodi
- Page 539 and 540:
532 IARC MONOGRAPHS VOLUME 82 Hansc
- Page 541 and 542:
534 IARC MONOGRAPHS VOLUME 82 Karak
- Page 543 and 544:
536 IARC MONOGRAPHS VOLUME 82 Latti
- Page 545 and 546:
538 IARC MONOGRAPHS VOLUME 82 Mäki
- Page 547 and 548:
540 IARC MONOGRAPHS VOLUME 82 Mutti
- Page 549 and 550:
542 IARC MONOGRAPHS VOLUME 82 Otten
- Page 551 and 552:
544 IARC MONOGRAPHS VOLUME 82 Salom
- Page 553 and 554:
546 IARC MONOGRAPHS VOLUME 82 Sulli
- Page 555 and 556:
548 IARC MONOGRAPHS VOLUME 82 Vodic
- Page 557 and 558:
550 IARC MONOGRAPHS VOLUME 82 pheny
- Page 560 and 561:
LIST OF ABBREVIATIONS USED IN THIS
- Page 562 and 563:
LIST OF ABBREVIATIONS 555 HPRT: hyp
- Page 564 and 565:
CUMULATIVE CROSS INDEX TO IARC MONO
- Page 566 and 567:
ortho-Anisidine 27, 63 (1982); Supp
- Page 568 and 569:
CUMULATIVE INDEX 561 Beryllium fluo
- Page 570 and 571:
CUMULATIVE INDEX 563 Chlorambucil 9
- Page 572 and 573:
CUMULATIVE INDEX 565 Clomiphene cit
- Page 574 and 575:
CUMULATIVE INDEX 567 Dibenzodioxins
- Page 576 and 577:
1,4-Dimethylphenanthrene 32, 349 (1
- Page 578 and 579:
Formaldehyde 29, 345 (1982); Suppl.
- Page 580 and 581:
Hypochlorite salts 52, 159 (1991) I
- Page 582 and 583:
CUMULATIVE INDEX 575 Malondialdehyd
- Page 584 and 585:
Methylthiouracil 7, 53 (1974); Supp
- Page 586 and 587:
CUMULATIVE INDEX 579 N-Nitrosodieth
- Page 588 and 589:
CUMULATIVE INDEX 581 Paracetamol 50
- Page 590 and 591:
Pronetalol hydrochloride 13, 227 (1
- Page 592 and 593:
CUMULATIVE INDEX 585 Sodium arsenit
- Page 594 and 595:
CUMULATIVE INDEX 587 Tetranitrometh
- Page 596 and 597:
V Vat Yellow 4 48, 161 (1990) Vinbl
- Page 598 and 599:
List of IARC Monographs on the Eval
- Page 600 and 601:
Volume 61 Schistosomes, Liver Fluke